Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
about
Metabolic syndrome in rheumatoid arthritisEffects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisManagement of moderate to severe psoriasis in patients with metabolic comorbiditiesTumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental ArthritisCardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis.Abnormal Glucose Metabolism in Rheumatoid ArthritisAnti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentInsulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases.Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.What is the future of targeted therapy in rheumatology: biologics or small molecules?Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis.Molecular targets related to inflammation and insulin resistance and potential interventionsInfluence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis.Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes.Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.Editorial: Insulin Resistance: Releasing the Brakes on Synovial Inflammation and Osteoarthritis?Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.Prevalence of metabolic syndrome in Behçet disease: a case-control study in Turkey.Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry.Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease.Effect of tumor necrosis factor-α inhibitors on ambulatory 24-h blood pressure.Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.Prevention of stroke in rheumatoid arthritis.Postprandial activation of metabolic and inflammatory signalling pathways in human peripheral mononuclear cells.
P2860
Q26822038-096CEC84-FEF9-4C3E-A0AB-80F400F21E3BQ26825588-72C30182-4AA9-4227-8F81-F9AE2E5473EAQ28087039-9204EBD8-E7B0-405D-86BF-4F9DC5D1679AQ28552434-1737EAFD-626E-40D0-B4D2-F7A20D9AE164Q30240180-BA8B3A40-A0D9-4F07-AED7-C048BFFFF31BQ33654451-4C4AF683-DCC3-4DBE-AA9E-5E03EFFBEDEEQ34444895-5D4B2FBC-CB01-49FA-A26C-6BE70ED3F864Q34563216-DEA2EBC6-BEC5-451D-B064-84972089A893Q34597334-2A982474-F3F5-4B05-86AF-CE66B03DD5B9Q35068543-60E74E49-C933-4AA2-A1EB-D3B209F18D85Q35118364-E39BE8F0-FA84-4448-9EB8-44F16D1DD371Q35257568-5D225A1E-252A-4E47-9E56-423A0DBC550EQ35596467-49555B84-7361-4F41-9F99-5565A5AC898CQ36294297-40CEBB7B-DC7E-4F7F-B49C-7D566813E608Q37000208-52F9D5AC-458D-43CC-AEEE-4932B5953E68Q37088215-81772A07-0A4F-4C82-A1D7-C9C389A12558Q37690079-CD2A985C-93CC-4095-BDA9-743F9D6CFC50Q37726817-5CD654D5-7DD2-4139-AC14-BFDA4B07BA7CQ38166661-EC229D14-739C-4574-82A8-298B2D44F4E8Q38181566-7574091F-B741-4E49-9161-C2E99D714697Q38260198-33EA5892-80C1-4E4D-93F8-622CB4866C0FQ38271745-3229EC2B-576A-484B-B161-3FB532519CACQ38323310-6DBCB026-7D98-4D7B-9D23-D7640113C48FQ43470680-473A9C30-B1A7-4550-934E-A201673F2536Q48508157-EA8231B2-19A3-4112-A0D4-967342B648F8Q48840645-CB6F34DF-04DA-4E65-ACFB-ED7796BE0D9EQ51244473-F860219B-8C67-44A9-8D33-6E01BB2558FEQ51329120-9971F6AB-DBAC-4497-BD0E-0FA08D1C5A0FQ51573622-16ECB893-D9BC-4C92-A662-8E9088898F46Q53502883-FFD33FC1-0AF5-408B-A74A-F3B05CB357FEQ54374548-5F9EE9A0-3059-4A01-849B-5412D4205B99
P2860
Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Anti-tumor necrosis factor the ...... s with high insulin resistance
@ast
Anti-tumor necrosis factor the ...... s with high insulin resistance
@en
type
label
Anti-tumor necrosis factor the ...... s with high insulin resistance
@ast
Anti-tumor necrosis factor the ...... s with high insulin resistance
@en
prefLabel
Anti-tumor necrosis factor the ...... s with high insulin resistance
@ast
Anti-tumor necrosis factor the ...... s with high insulin resistance
@en
P2093
P2860
P356
P1476
Anti-tumor necrosis factor the ...... s with high insulin resistance
@en
P2093
Amalia Raptopoulou
Dimitra Virla
Dimitrios Kardassis
Dimitrios T Boumpas
George Bertsias
Ilias Stagakis
Melina Kavousanaki
Prodromos I Sidiropoulos
Stylianos Karvounaris
P2860
P2888
P356
10.1186/AR3874
P577
2012-06-12T00:00:00Z
P5875
P6179
1030505978